Patients & CaregiversHealthcare Professionals - Opens new windowWorldwide - Opens new window
HomeAbout Merck Products Newsroom Investor Relations CareersResearchLicensingThe Merck Manuals

The Merck Manual of Geriatrics logo
red line
click here to go to the Contents page of The Merck Manual of Geriatrics
click here to go to the title page of The Merck Manual of Geriatrics
click here to search The Merck Manual of Geriatrics
click here to go to the Index of The Merck Manual of Geriatrics
red line
Section 15. Dermatologic and Sensory Organ Disorders
Chapter 123. Common Skin Disorders
Topics:    Introduction | Pruritus | Xerosis | Rosacea | Dermatitis | Venous Ulcers | Psoriasis | Bullous Diseases | Herpes Zoster | Onychomycosis

red line

Onychomycosis

(Tinea Unguium)

A fungal infection of the nails, most often caused by Trichophyton sp.

Onychomycosis is caused by dermatophytes, yeast, and nondermatophytic molds, depending on the geographic region and the patient's status. In temperate zones, dermatophytes are most commonly implicated, particularly Trichophyton sp.

The nails are yellow and thickened with distal separation of the nail plate from the nail bed (onycholysis). The diseased nail can serve as a reservoir of fungus, which can lead to recurrent tinea pedis, a known risk factor for cellulitis.

Diagnosis of onychomycosis is made clinically and confirmed by a potassium hydroxide preparation, fungal culture, or nail clipping for periodic acid-Schiff staining.

Although not all patients with onychomycosis require treatment, patients with pain, diabetes mellitus, or peripheral vascular disease should generally be treated with itraconazole 200 mg po daily or terbinafine 250 mg po daily. Treatment must continue until the affected nails have grown out, which usually takes 10 to 12 months in the elderly. Because these drugs are retained in the nails, patients can also be treated twice daily for 1 week of each month with comparable cure rates.

Contact Merck Site MapPrivacy PolicyTerms of UseCopyright 1995-2008 Merck & Co., Inc.